Evidence map›Paper›PMID 39643618›Full record

ArticleNature communications2024

Ratiometric fluorescence probes for visible detection and accurate identification of MPEA vapor.

Xin Miao, Chunxiao Wu, Yuanxing Xia, Shilong Yu, Feng Li, Ming Zhang

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xin MiaoState Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun, 130012, P. R. China.
Chunxiao WuState Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun, 130012, P. R. China.
Yuanxing XiaDepartment of Fundamental Study of Public Security, Criminal Investigation Police University of China, Shenyang, 110854, P. R. China.
Shilong YuState Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun, 130012, P. R. China.
Feng LiState Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun, 130012, P. R. China.ORCID http://orcid.org/0000-0001-5236-3709
Ming ZhangState Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun, 130012, P. R. China. zhming@jlu.edu.cn.ORCID http://orcid.org/0000-0001-6165-5973

Funding

National Natural Science Foundation of China (National Science Foundation of China) 21875083
6 · The paper itself

Abstract

Methamphetamine (MA), as one kind of overflowed synthetic illicit drugs, has posed severe threats to health and social security. However, the on-site and visible fluorescence detection to MA remains limited. Herein, through covalently coupling diphenylacridine (DPA) and dimethylacridine (DMA) with pyridine, two ratiometric fluorescence probes (PyDPA and PyDMA) are constructed, which present rapid response, bathochromic-shifts over 100 nm and visible fluorescence color changes from blue to cyan upon the exposure to methylphenethylamine (MPEA, a simulant of MA). And the similar responses are observed for MA in confiscated samples. Further, a smartphone-based quantitative detected system is established to provide the on-site trace detection of MPEA as ppb level. Specially, PyDPA or PyDMA can identify MPEA from its interferences according to the unique ratiometric response based on their dual-emission-enhancement. Here, we show two ratiometric fluorescence probes to MA and MPEA with high potential for on-site application.

Identifiers

PMID39643618
PMCPMC11624257

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.